Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG

February 17, 2018

Amplifying the patient voice and supporting science: an interview with Adrienne Bell-Cors Shapiro

In this interview, filmed exclusively at the World Stem Cell Summit (22-26 January, 2018, Miami, Florida), meet Adrienne Bell-Cors Shapiro, Founder of Axis Advocacy, which aims improve the lives of patients and caregivers who are dealing with sickle cell disease. Adrienne discusses how she believes stem cell science is the key to curing sickle cell […]

February 8, 2018

#TalkingRegMed Special: World Stem Cell Summit highlights with Adam Price-Evans

In this special episode of #TalkingRegMed, Freya Leask, RegMedNet, and Adam Price-Evans, Commissioning Editor, Regenerative Medicine, discuss highlights from the World Stem Cell Summit (22-26 January, Miami, Florida), co-located with Phacilitate’s Cell and Gene Therapy World and Immuno-Oncology World. In particular, they comment on their favorite talks and panels, and key takeaways from this ‘ecoystem’ […]

February 6, 2018

RegMedNet Interview with Bernard Siegel

In this interview, filmed exclusively at the World Stem Cell Summit (22-26 January, 2018, Miami, Florida), Bernie Siegel discusses how the Regenerative Medicine Foundation came to be set up. He also shares his thoughts for the future of regenerative medicine and in the importance of considering the whole regenerative medicine ecosystem.

February 1, 2018

Anti-Aging Pioneer Aubrey de Grey: “People in Middle Age Now Have a Fair Chance”

Aubrey de Grey at the World Stem Cell Summit in Miami on January 25, 2018. (Courtesy Kira Peikoff) Eye Openers January 30, 2018 14 minute read by: Kira Peikoff READ FULL ARTICLE HERE Aging is not a mystery, says famed researcher Dr. Aubrey de Grey, perhaps the world’s foremost advocate of the provocative view […]

January 30, 2018

World Stem Cell Summit 2018 in Miami Solidifies Regenerative Medicine as the Future of Healthcare

Miami, FL – January 30, 2017 – The international regenerative medicine community concluded a week sharing breakthroughs, facing challenges and developing collaborations at the 13th World Stem Cell Summit (WSCS) at the Hyatt Regency Miami, January 22-26, 2018. The cure and treatment-focused meeting featured presentations on miraculous innovations in identifying the causes of disease, growing […]

January 26, 2018

Joe and Jill Biden among several honored at World Stem Cell Summit gala

By Jessica Barrios South Florida News Service (Photo courtesy Howard Miller) MIAMI – January 25, 2018 – Greg Simon, president of the Biden Cancer Initiative gives an acceptance speech on behalf of the Bidens. Former Vice President Joe Biden and Dr. Jill Biden were among several leaders, innovators and professionals in the regenerative medicine field […]

January 26, 2018

Interview: Dr. Anthony Atala discusses the future of regenerative medicine

By Nick Rodriguez South Florida News Service (Photo credit: Nick Rodriguez)MIAMI-January 25, 2018 – Dr. Anthony Atala, director of the Wake Forest Institute for Regenerative Medicine and the W.H. Boyce professor and chair of the Department of Urology at Wake Forest University, spoke about regenerative medicine in four different sessions at the 13th World Stem Cell Summit in Downtown Miami. A practicing surgeon […]

January 23, 2018

Longeveron to Play Prominent Role at the World Stem Cell Summit in Miami

MIAMI, Jan. 22, 2018 /PRNewswire/ — Longeveron LLC, regenerative medicine company, announced that it will help roll out the red carpet when investigators from around the globe converge on the company’s hometown of Miami for the 2018 World Stem Cell Summit, January 22-26 at the Hyatt Regency. Longeveron Co-Founder and Chief Science Officer Joshua M. […]

January 22, 2018

Aging Frailty with Influenza Vaccine Trial announced by Longeveron

America is facing one of the worst influenza seasons in recent history. The influenza virus is one of the top ten causes of death in elderly people. Longeveron is conducting a multi-center, randomized, placebo controlled trial using its Longeveron Mesenchymal Stem Cells (LMSCs) to measure the safety of treatment with LMSCs to improve vaccine response […]

January 22, 2018

Longeveron Alzheimer’s Disease Trial

Allogeneic Human Mesenchymal Stem Cell Infusion Versus Placebo in Patients with Alzheimer’s Disease. Longeveron’s Phase I, prospective, randomized, placebo-controlled, double-blinded study is designed to test the safety and efficacy of Longeveron Mesenchymal Stem Cells (LMSCs) for the treatment of subjects with clinically diagnosed Alzheimer’s disease. Longeveron has completed the FDA mandated safety run in and […]

January 22, 2018

Longeveron Aging Frailty Phase 2b Trial

Longeveron is currently enrolling subjects in its Phase 2b multi-center clinical trial designed to test the safety and efficacy of Longeveron Mesenchymal Stem Cells (LMSCs) for the treatment of subjects with clinically diagnosed with Aging Frailty. This is the only known trial in the world underway to use MSCs to treat Aging Frailty. Frailty is […]